News | January 26, 2009

CardioWest Artificial Heart Sends Patient Home for the Holidays

January 27, 2009 - Thanks to the CardioWest temporary Total Artificial Heart and portable driver, recipient Mr. Potiron was able to leave University Hospital of Nantes for the first time in more than a year to celebrate Christmas at home.

"We have waited for a long time to put one of our patients on the portable driver because it is in limited supply," explained Prof. Daniel Duveau, Medical Director for the Thorax Institute at University Hospital of Nantes. "We eagerly await the arrival of the new Companion Driver System so that more of our artificial heart patients can enjoy a near-normal quality of life at home. Many of these patients can shop, travel, visit family and live life like people with human hearts. Quality of life is very important because these patients can wait up to two years for a matching human heart due to the shortage of donors."

"Without the CardioWest artificial heart, I wouldn't be here today. I feel healthier than I have in years," said Mr. Potiron, who received his artificial heart on Nov. 18, 2007, after suffering two heart attacks.

Originally designed as a permanent replacement heart, the CardioWest artificial heart is currently approved as a bridge to human heart transplant for patients dying from end stage biventricular failure.

In Q1 2009, SynCardia will apply for CE approval of the Companion Driver in Europe and apply to the FDA to conduct an IDE clinical study of the Companion Driver in the U.S. The Companion Driver is designed for use in the hospital and at home. SynCardia projects a 400 percent increase in the number of patients benefiting from the CardioWest artificial heart in the 24 months following regulatory approvals.

For more information:syncardia.com

Related Content

St. Jude Medical, HeartMate 3 LVAS, MOMENTUM 3 IDE study results, AHA Scientific Sessions 2016
News | Ventricular Assist Devices (VAD)| December 08, 2016
St. Jude Medical Inc. announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late-breaking clinical trial...
SynCardia, Chapter 11 reorganization, sale, Total Artificial Heart
News | Artificial Heart| September 13, 2016
August 29, 2016 — SynCardia Systems, manufacturer of the...
Carmat, bioprosthetic artificial heart, PIVOTAL study, first implantation, heart failure
News | Artificial Heart| September 09, 2016
Carmat announced that the first implantation of its bioprosthetic artificial heart within the framework of the PIVOTAL...
SynCardia acquired, Versa Capital Management, chapter 11
News | Business| July 07, 2016
SynCardia Systems Inc. announced that it has entered into an asset purchase agreement (“APA”) with an affiliate of...
SynCardia Total Artificial Heart, TAH-t, documentary, Retro Reports, The New York Times
News | Artificial Heart| March 24, 2016
March 24, 2016 — A new documentary produced by Retro Report for The New York Times looks at the history and
Bryan Tyo, Baylor University Medical Center, bridge to transplant, Total Artificial Heart
News | Artificial Heart| March 18, 2016
A surgical team at Baylor University Medical Center at Dallas successfully performed a heart transplant on a patient...
HeartWare, ENDURANCE2 trial, destination therapy, HVAS, HeartWare Ventricular Assist System
News | Ventricular Assist Devices (VAD)| August 11, 2015
HeartWare International Inc. announced that enrollment in the ENDURANCE2 destination therapy clinical trial has been...
News | January 30, 2015
SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the...
syncardia, artificial heart

SynCardia Total Artificial Heart

News | November 24, 2014
A 19-year-old woman was successfully implanted with the SynCardia temporary Total Artificial Heart and bridged to a...
Overlay Init